INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 349 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,380,488 | -67.1% | 240,415 | -55.2% | 0.00% | -66.7% |
| Q4 2023 | $16,347,884 | -46.7% | 536,172 | -28.7% | 0.00% | -50.0% |
| Q2 2023 | $30,673,411 | +19.4% | 752,168 | +9.1% | 0.01% | 0.0% |
| Q1 2023 | $25,691,031 | -14.1% | 689,322 | -19.6% | 0.01% | -14.3% |
| Q4 2022 | $29,910,429 | -19.3% | 857,278 | +29.4% | 0.01% | -30.0% |
| Q3 2022 | $37,063,371 | +18.1% | 662,319 | +9.2% | 0.01% | +25.0% |
| Q2 2022 | $31,385,866 | -13.8% | 606,373 | +21.1% | 0.01% | 0.0% |
| Q1 2022 | $36,393,645 | -30.3% | 500,807 | +13.4% | 0.01% | -27.3% |
| Q4 2021 | $52,234,000 | -36.4% | 441,760 | -27.8% | 0.01% | -38.9% |
| Q3 2021 | $82,118,000 | +22.3% | 612,136 | +47.6% | 0.02% | +20.0% |
| Q2 2021 | $67,147,000 | +71.2% | 414,719 | -15.1% | 0.02% | +66.7% |
| Q1 2021 | $39,215,000 | +12349.2% | 488,636 | +3157.6% | 0.01% | – |
| Q2 2020 | $315,000 | -64.4% | 15,000 | -77.8% | 0.00% | – |
| Q4 2016 | $886,000 | – | 67,571 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 1,859,926 | $301,141,000 | 48.58% |
| Burrage Capital Management LLC | 63,634 | $10,303,000 | 10.33% |
| Elmwood Wealth Management, Inc. | 67,174 | $10,876,000 | 5.73% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 300,327 | $48,626,000 | 4.72% |
| Discovery Value Fund | 929,669 | $150,523,000 | 4.08% |
| Ikarian Capital, LLC | 294,400 | $47,667,000 | 3.85% |
| Ally Bridge Group (NY) LLC | 93,127 | $15,078,000 | 3.75% |
| GREAT POINT PARTNERS LLC | 100,000 | $16,191,000 | 3.40% |
| ARK Investment Management | 7,684,441 | $1,244,188,000 | 2.32% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $18,043,000 | 2.30% |